Your institution may have access to this item. Find your institution then sign in to continue.
Title
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study.
Authors
Van Gaal LF; Rissanen AM; Scheen AJ; Ziegler O; Rössner S; RIO (Rimonabant In Obesity)-Europe Study Group; Van Gaal, Luc F; Rissanen, Aila M; Scheen, André J; Ziegler, Olivier; Rössner, Stephan; RIO-Europe Study Group